CHINA TRIALS 2008 Advisory Board

James Cai, Ph.D. Vice President, Healthcare Policy Research ASTRAZENECA	Frank Fan, M.D., MBA Medical Director WYETH	James Garner M.D. Vice President Clinical & Medical Affairs PROGEN PHARMACEUTICALS

Min Irwin, M.D., Ph.D. Medical Director of BSP BAYER HEALTHCARE	Zili Li, M.D., MPH Head of Asia Pacific Regulatory Policy MERCK & CO.	Mao Mao, M.D., Ph.D. Director/Project Liaison China MERCK & CO.

Bradley Marchant, M.D. Executive Director Head of Clinical Medicine Asia PFIZER CHINA R&D CENTER	Jay Mei, M.D., Ph.D. Executive Director, Clinical Development CELGENE	Ole Molskov Bech, M.D. Vice President Clinical & Medical Director NOVO NORDISK

Fidela Li Moreno, M.D. Executive Director Global Development Operations AMGEN	Bin Peng, M.D., Ph.D. Director Clinical Pharmacology GLAXOSMITHKLINE	Rong (Rose) Qiu, M.D. Head of Global Clinical Operations, Asia Pacific JOHNSON & JOHNSON

Cezary Statuch, M.D. Executive Medical Director Global Medical Affairs BRISTOL-MYERS SQUIBB	Ling Su, Ph.D. Vice President, Clinical Research and Development Asia Pacific WYETH	Jingsong Wang, M.D. Director Discovery Medicine & Clinical Pharmacology BRISTOL-MYERS SQUIBB

About Your Organizer

Jon E. Liong, Managing Partner, LYCHEE GROUP
Jon brings 9 years of success in the strategic planning, organization, and execution of over 100 pharmaceutical and biotech business-to-business conferences. He conceived and launched the "IMPACT CHINA: Pharmaceutical Global R&D" series, which was the first-ever Western-organized conference covering China's life sciences industry. The meeting helped foster early collaborations between Western companies and all aspects of China's nascent pharmaceutical industry.